As of 2024-12-12, the EV/EBITDA ratio of Guardant Health Inc (GH) is -15.75. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GH's latest enterprise value is 4,962.67 mil USD. GH's TTM EBITDA according to its financial statements is -315.12 mil USD. Dividing these 2 quantities gives us the above GH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.7x - 13.6x | 12.0x |
| Forward P/E multiples | 15.0x - 21.5x | 18.4x |
| Fair Price | (42.66) - (39.20) | (43.28) |
| Upside | -219.6% - -209.9% | -221.4% |
| Date | EV/EBITDA |
| 2024-12-11 | -15.94 |
| 2024-12-10 | -15.70 |
| 2024-12-09 | -16.03 |
| 2024-12-06 | -16.22 |
| 2024-12-05 | -16.32 |
| 2024-12-04 | -16.71 |
| 2024-12-03 | -15.80 |
| 2024-12-02 | -15.69 |
| 2024-11-29 | -15.73 |
| 2024-11-27 | -15.53 |
| 2024-11-26 | -15.24 |
| 2024-11-25 | -15.65 |
| 2024-11-22 | -14.57 |
| 2024-11-21 | -13.91 |
| 2024-11-20 | -13.80 |
| 2024-11-19 | -13.80 |
| 2024-11-18 | -13.12 |
| 2024-11-15 | -13.18 |
| 2024-11-14 | -13.61 |
| 2024-11-13 | -14.16 |
| 2024-11-12 | -13.42 |
| 2024-11-11 | -13.28 |
| 2024-11-08 | -12.98 |
| 2024-11-07 | -12.98 |
| 2024-11-06 | -11.68 |
| 2024-11-05 | -10.99 |
| 2024-11-04 | -11.02 |
| 2024-11-01 | -10.78 |
| 2024-10-31 | -10.35 |
| 2024-10-30 | -10.81 |
| 2024-10-29 | -10.31 |
| 2024-10-28 | -10.47 |
| 2024-10-25 | -9.81 |
| 2024-10-24 | -9.69 |
| 2024-10-23 | -9.77 |
| 2024-10-22 | -9.75 |
| 2024-10-21 | -9.94 |
| 2024-10-18 | -10.15 |
| 2024-10-17 | -9.88 |
| 2024-10-16 | -10.24 |
| 2024-10-15 | -10.22 |
| 2024-10-14 | -10.13 |
| 2024-10-11 | -10.16 |
| 2024-10-10 | -9.85 |
| 2024-10-09 | -9.96 |
| 2024-10-08 | -10.02 |
| 2024-10-07 | -10.14 |
| 2024-10-04 | -10.46 |
| 2024-10-03 | -10.31 |
| 2024-10-02 | -10.53 |